David E. Joyce - Concepedia

Author

David E. Joyce

Eli Lilly (United States)ORCID

Also Known As

D JOYCE, D. E. Joyce, D. Joyce, D.E. Joyce, Daniel Joyce, David E Joyce, David E. Joyce, David Joyce

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

David E. Joyce is an author at Eli Lilly (United States) specializing in medicine, sepsis, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	721
2	Cell Biology	1	1	19
3	Critical Care Medicine	1	1	246
4	Endocrinology	1	1	19
5	Immunology	1	1	19

David E. Joyce

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis David E. Joyce, Larry Gelbert, A Ciaccia, Journal of Biological Chemistry	2001	650
Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation J. F. Dhainaut, S. Betty Yan, David E. Joyce, Journal of Thrombosis and Haemostasis ThrombosisSevere SepsisHematologyIntravascular CoagulationSepsis	2004	427
Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni Richard G. Wunderink, Sachin Yende, Pierre‐François Laterre, CHEST Journal Critical Care MedicineSevere SepsisClinical TherapeuticAcute CarePatient Safety	2003	246
Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia Bryce A. Kerlin, S. Betty Yan, Berend Isermann, Blood	2003	169
Human Recombinant Activated Protein C in Meningococcal Sepsis Gregory Wcisel, David E. Joyce, Arna Guðmundsdóttir, CHEST Journal Medical MicrobiologyMeningococcal SepsisVirulence FactorPathogenesisSepsis	2002	29
Functional Interactions Between the Thrombin Receptor and the T-Cell Antigen Receptor in Human T-Cell Lines David E. Joyce, Yan Chen, Rochelle A. Erger, Blood	1997	25
17β-Estradiol, But Not Raloxifene, Decreases Thrombomodulin in the Antithrombotic Protein C Pathway Mark A. Richardson, David T. Berg, David S. Calnek, Endocrinology Decreases ThrombomodulinImmunologyPharmacotherapyInflammationMolecular Pharmacology	2000	19

Page 1